Michael Robert Kendall Clayton

age:

50 years

appointments:

40 active

3 prior

primary industry:

Financial service activities, except insurance and pension funding

about Michael

Since 2020, Mr Clayton has been a director of 43 companies, the current directorship have a combined turnover of approximately £1.7b.

Combined Valuation

£32.4b

Combined Turnover

£1.7b

active directorships over time

company
turnover
valuation
start
end
status
role
abbott uk investments limited-£9.3bMar 2020-OpenDirector
abbott asia holdings limited£64.4m£2.5bMar 2020-OpenDirector
abbott asia holdings limited£64.4m£2.5bMar 2020-OpenDirector
abbott asia investments limited-£2.4bMar 2020-OpenDirector
abbott asia investments limited-£2.4bMar 2020-OpenDirector
abbott equity holdings unlimited-£2.3bMar 2020-OpenDirector
abbott equity holdings unlimited-£2.3bMar 2020-OpenDirector
abbott laboratories limited£539.5m£1.7bMar 2020-OpenDirector
abbott laboratories limited£539.5m£1.7bMar 2020-OpenDirector
abbott (uk) holdings limited£151.2m£1.7bApr 2020-OpenDirector
abbott (uk) holdings limited£151.2m£1.7bMar 2020-OpenDirector
knoll uk investments unlimited£8.5m£352.6mMar 2020-OpenDirector
abbott capital india limited£32.9m£327.1mMar 2020-OpenDirector
abbott capital india limited£32.9m£327.1mMar 2020-OpenDirector
abbott australasia holdings limited-£202.6mMar 2020-OpenDirector
abbott australasia holdings limited-£202.6mMar 2020-OpenDirector
abbott (uk) finance limited£22.4m£183.6mMar 2020-OpenDirector
abbott healthcare products ltd£2.3m£135.7mMar 2020-OpenDirector
murex biotech limited-£86.6mMar 2020-OpenDirector
abbott uk subsidiary limited£5.3m£79.1mDec 2021-OpenDirector
cozart limited-£32.4mMay 2022-OpenDirector
cozart limited-£32.4mMay 2022-OpenDirector
abbott toxicology limited£34.6m£27.5mMay 2022-OpenDirector
abbott toxicology limited£34.6m£27.5mMay 2022-OpenDirector
abbott uk subsidiary 2 limited£2.2m£21.2mDec 2021-OpenDirector